Join us at the 3rd Cancer Targets & Therapeutics Conference Feb. 27-28

February 27, 2012 - February 28, 2012
Las Vegas, NV

With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets & therapeutics provides new opportunities for the prevention and treatment of several major disease systems. This conference examines new and emerging targets and therapeutics in the area of cancer research. Speakers at the event provide case studies of emerging targets in order to address some of the issues surrounding target-based drug discovery and development.

The conference will be assembled into these sessions:
Session I: Novel Protein Kinase inhibitors and beyond the Kinome
Session II: Functional Genomics and Novel Cancer Targets
Session III: Cancer Stem Cells, Metabolism, and Epigenetics
Session IV: Cancer Immunotherapy
Session V: Combinational Therapy Rationale and Strategy
Session VI: Patient Selection and Translational Oncology

Come see us present two posters: “Spray-Dried Dispersion Formulation Screening for Low Solubility Compounds," presented by Corey Bloom, Ph.D. and “A Novel Inhalable Camptothecin Formulation for the Treatment of Lung Cancer," presented by Jeff Breit, Ph.D.